US 11958910
Bispecific antigen binding molecules that bind HER2, and methods of use thereof
granted A61KA61K2039/505A61K47/6803
Quick answer
US patent 11958910 (Bispecific antigen binding molecules that bind HER2, and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/505, A61K47/6803, A61K47/68033, A61K47/6855